Brady, et al. "A randomized phase III trial of IV carboplatin and paclitaxel x 3 courses followed by ob servation versus weekly maintenance low-dose paclitaxel in patients with early -stage ovarian carcinoma: a Gynecologic Oncology Group Study." Gynecol Oncol 122(1): 89-94. 117.